Dostarlimab
Medication for endometrial cancer treatment
Dostarlimab ▸ Facts ▸ Comments ▸ News ▸ Videos
Dostarlimab, sold under the brand name Jemperli, is a monoclonal antibody used as a medication for the treatment of endometrial cancer.
0 shares | ShareTweetSavePostSend |
You Might Like
No news matches foundSorry, we were unable to find any results in our database for your queryFree news archive accessDid you know? You are eligible to search our news archive with millions of news references free of charge. To do this, please sign in first at the top of the screen. • Information about free access to our news archive Search this site and the web: |